In a patent dispute that resolved with notable speed, VoltStar Technologies, Inc. filed suit against consumer electronics accessory giant Spigen, Inc. in November 2023, alleging infringement of a reissued U.S. patent covering GaN (gallium nitride) charging technology. The case, docketed as 8:23-cv-02101 in the U.S. District Court for the Central District of California, was dismissed following settlement just 152 days after filing — well below the average district court patent case timeline.

At stake were three of Spigen’s commercially prominent USB-C power delivery products: the ArcStation Pro GaN 652, the Spigen ArcStation USB-C PD 27W, and the Spigen PowerArc ArcStation Pro. The asserted patent, USRE048794E (a reissue of U.S. Application No. 16/209,373), covers technology in the rapidly expanding GaN fast-charging market.

For patent attorneys, IP professionals, and R&D teams navigating the competitive consumer charging space, this case offers instructive lessons about reissue patent strategy, venue selection, litigation pacing, and the economics of early settlement in technology patent disputes.

Case Overview

The Parties

The Patent at Issue

The asserted patent, USRE048794E, is a reissue patent — a procedurally significant designation. Reissue patents are granted by the USPTO when an inventor seeks to correct errors in an originally issued patent, often broadening or clarifying claims. This mechanism can strategically reposition a patent’s scope to capture products that may not have been covered under the original grant, making reissue patents a powerful assertion tool.

The corrected application number (US16/209373) anchors the patent’s priority chain and is central to evaluating claim scope and validity. The underlying technology relates to GaN-based power conversion architecture used in compact USB-C fast chargers — a field characterized by rapid innovation and dense patent activity.

• • USRE048794E — Reissued patent covering GaN (gallium nitride) charging technology.

The Accused Products

The three accused products — the ArcStation Pro GaN 652, ArcStation USB-C PD 27W, and PowerArc ArcStation Pro — represent Spigen’s flagship charging lineup. These products are actively sold through major retail and e-commerce channels, meaning any injunctive relief or ongoing royalty obligation would carry meaningful commercial consequences for Spigen’s business operations.

Litigation Timeline & Procedural History

VoltStar filed its complaint on November 8, 2023, selecting the Central District of California — a venue with established patent litigation infrastructure and personal jurisdiction over Spigen, a California-based company. Venue selection here was strategically straightforward given Spigen’s domicile.

The case closed on April 8, 2024, after just 152 days — a remarkably compressed timeline by patent litigation standards, where cases routinely extend 18 to 36 months before trial. This rapid resolution strongly suggests that substantive litigation activity — including claim construction briefing and early motion practice — prompted both parties to assess settlement economics quickly.

The case proceeded at the district court (first instance) level, meaning no appellate or PTAB inter partes review proceedings are reflected in the available record. The absence of an IPR petition filing within the case timeline may itself be a strategic data point worth noting.

Legal Representation

Plaintiff VoltStar was represented by Matthew Laurence Rollin of Sriplaw PA, a firm known for intellectual property enforcement litigation.

Defendant Spigen retained Fish & Richardson LLP — one of the nation’s preeminent patent litigation firms — with a defense team comprising Alexander H. Martin, Lance E. Wyatt, Neil J. McNabnay, and Rodeen Talebi. Fish & Richardson’s involvement signals that Spigen was prepared to mount a vigorous, well-resourced defense.

The Verdict & Legal Analysis

Outcome

The Court issued a dismissal order upon notification that the parties had reached a settlement agreement. The dismissal was entered without prejudice and without costs, with the Court retaining jurisdiction for 30 days to reopen the matter if settlement was not consummated. The specific financial terms of the settlement were not disclosed in the public record.

This structure — a conditional dismissal preserving reopening rights — is standard in patent settlement practice and protects both parties during the execution phase of any licensing or payment arrangement.

Verdict Cause Analysis

The case was filed as a straightforward infringement action. Because the matter settled before substantive rulings on claim construction, validity, or infringement were issued, no published judicial analysis of USRE048794E‘s claim scope exists from this proceeding.

However, several strategic dynamics likely shaped the parties’ calculus:

• Reissue patent risk for defendants: Reissue patents, having undergone re-examination at the USPTO, can carry enhanced presumptions of validity on corrected claims. Challenging a reissue patent’s validity requires overcoming both the original grant and the reissuance review — a higher litigation burden for accused infringers.
• Fish & Richardson’s defense profile: The assembly of a four-attorney defense team from a top-tier patent litigation firm suggests Spigen anticipated filing substantive invalidity or non-infringement motions. The relatively fast settlement may indicate that early case assessment revealed sufficient risk on either validity or infringement to make resolution economically preferable to full-scale litigation.
• Commercial exposure: With three active retail products accused, Spigen faced potential injunctive relief that could disrupt product sales — a significant pressure point favoring early resolution.

Legal Significance

Because the case settled without a judicial ruling, USRE048794E remains untested in federal court. This has meaningful implications: the patent’s claim scope has not been construed by any district court, and no invalidity findings exist. VoltStar retains a patent with full presumptive validity and undefined (from a litigation record perspective) claim boundaries — potentially usable in future assertion campaigns against other GaN charger manufacturers.

Strategic Takeaways

For Patent Holders: Reissue patents can be effective assertion vehicles in fast-evolving technology markets where original claim language may not have anticipated subsequent product implementations. VoltStar’s strategy — asserting a reissued patent against commercially active products — is a reproducible model in hardware-adjacent IP enforcement.

For Accused Infringers: Early engagement with experienced patent litigation counsel (as Spigen demonstrated with Fish & Richardson) enables rapid case assessment. When facing reissue patents with potentially broadened claims and commercially sensitive products, quantifying settlement cost against litigation cost early is critical.

For R&D Teams: GaN charging technology is a dense patent landscape. Any product development in USB-C power delivery, fast-charging IC design, or compact power conversion architecture should include a Freedom to Operate (FTO) analysis that specifically searches reissue patent families — not just original grants.

Industry & Competitive Implications

The GaN fast-charger market has become a significant battleground for patent assertion. As GaN technology achieves mainstream adoption across consumer electronics, the density of patent filings — and reissue applications seeking broader claim coverage — will continue to increase.

This case reflects a broader trend: patent holding entities targeting established consumer electronics brands with commercially successful GaN product lines. Spigen’s ArcStation products occupy the mid-to-premium retail tier, making them high-visibility enforcement targets.

The 152-day resolution also reflects the settlement economics of patent cases involving mid-market consumer products: litigation costs at Fish & Richardson billing rates, combined with product sales disruption risk, frequently make early licensing arrangements more economical than prolonged defense — even when invalidity arguments may be available.

For companies operating in adjacent spaces — wireless charging, USB4 power delivery, multi-port GaN adapters — this case signals that reissue patent holders are actively monitoring the consumer charging ecosystem. Proactive IP portfolio audits and design-around strategies based on current patent family landscapes are advisable risk management steps.